Global Agencies Seek Clearer Steer On AI In Drug Development & Regulation
Report Describes Possible Use Of Apps For CNS Drugs, Pharmacovigilance
Regulators’ experiences and two hypothetical case studies form the basis of a set of recommendations on the use of artificial intelligence in areas such as safety signal detection and improving decision making, which have just been published by the International Coalition of Medicines Regulatory Authorities.
